Oxazepam impurity 7 CAS 18878-19-8
| CAS No. | 18878-19-8 |
| Molecular Formula | C16H13ClN2O2 |
| Molecular Weight | 300.74 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Oxazepam impurity 7 (CAS 18878-19-8), a pharmacopoeial impurity reference standard (molecular formula C16H13ClN2O2, MW 300.74 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Oxazepam impurity 7 (C16H13ClN2O2) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Oxazepam impurity 7 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C16H13ClN2O2 |
| Molecular Weight | 300.74 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 11.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1962 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 2 |
Related Oxazepam Standards
Recommended Standards
- Tegoprazan impurity 48 (CAS CATO-C4X-229748)
- Tivozanib Impurity 6 (CAS CATO-C4X-34006)
- Tegoprazan Impurity 112 (CAS CATO-C4X-2297112)
- Hydrochlorothiazide-13C,d2 (CAS 1190006-03-1)
- Rivaroxaban Impurity 128 (CAS 2304798-51-2)
- Moxifloxacin Impurity 15 (CAS 2205053-60-5(Free Base))
- Cefmetazole Impurity 44 (CAS CATO-C4X-150744)
- 5-Bromo-2,2-dimethylindoline hydrochloride (CAS 2230913-73-0)
- 2-Chloro-1-(4-chlorobenzyl)-1H-benzo[d]imidazole, 95% (CAS 131705-80-1)
- 2-Methyl-4-pyrrolidinomethyl benzophenone (CAS 898775-91-2)
- 7-Methylidene-1,4-dioxaspiro[4.5]decane (CAS 104598-81-4)
- Tosufloxacin Tosylate Hydrate (CAS 1400591-39-0)
- 1-Boc-4-(4-bromo-2-pyridyl)piperazine (CAS 1197294-80-6)
- His-Cyclic-Semaglutide (CAS CATO-C4X-2226182)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com